MSB 4.66% $1.46 mesoblast limited

Growing doubt on COVID-19 Application, page-3349

  1. 1,019 Posts.
    lightbulb Created with Sketch. 344
    Appreciate the response and have looked through the trial link. Have read a lot of trial data. Stayed up all night for 9-1 vote. this also led me to sell as that was smelly too.....especially the Dr of Indian decent that had no idea why she was in the room and asked ridiculous questions.

    saying "you cant look at mortality stats" across the board I do not accept. If MSB is to be a successful commercial operation their drugs need to give you a better outcome than competitors or no treatment, Japanese patients have forked out anywhere from $10 - $100 million (from above posts). There is no approved treatment in the US for gvhd u/12.

    Forget trials, studies, endpoints, single arm, blind, double blind SURELY Japanese kids have a better chance of survival than US kids with so much of the product being sold.

    Not being a naysayer, downramper etc, I want MSB to be successful but this has urked me for years
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.46
Change
0.065(4.66%)
Mkt cap ! $1.667B
Open High Low Value Volume
$1.41 $1.50 $1.40 $5.699M 3.943M

Buyers (Bids)

No. Vol. Price($)
5 122380 $1.46
 

Sellers (Offers)

Price($) Vol. No.
$1.46 11015 2
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.